Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH) has announced that its subsidiary, Shanghai Sine Promod Pharmaceutical Co., Ltd., has obtained a Drug Registration Certificate from the National Medical Products Administration for Omeprazole and Sodium Bicarbonate for Oral Suspension (I), granting approval for production.

The newly approved product, which contains 20mg of omeprazole and 1680mg of sodium bicarbonate per sachet, is primarily indicated for the short-term treatment of active duodenal ulcers and gastroesophageal reflux disease.